Cathy Eng: Role for IO therapy in MSS with Dr. Neil Segal and Dr. Michael Overman

Cathy Eng shared on X:

“Last debate Great Debates & Updates on Day 1 w Dr. Neil Segal, Memorial Sloan Kettering Cancer and Dr. Michael Overman, Memorial Sloan Kettering Cancer: Is there a role for IO therapy in MSS (pMMR) patients? Yes or no? More GREAT speakers tomorrow on Day 2. Yelena Y. Janjigian.”

Source: Cathy Eng/X

Cathy Eng is a Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology and Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center. She also holds the David H. Johnson Endowed Chair of Surgical and Medical Oncology. Dr. Eng was previously a Professor of Medical Oncology at The University of Texas MD Anderson Cancer Center.